3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Lymphoma, Large B-Cell, Diffuse
88
Lymphoma, Follicular
52
Lymphoma
52
Lymphoma, Non-Hodgkin
47
Lymphoma, Mantle-Cell
46
Lymphoma, B-Cell, Marginal Zone
45
Leukemia, Lymphocytic, Chronic, B-Cell
40
Lymphoma, B-Cell
32
Recurrence
21
Burkitt Lymphoma
21
Waldenstrom Macroglobulinemia
16
Precursor Cell Lymphoblastic Leukemia-Lymphoma
16
Neoplasms
16
Leukemia
11
Leukemia, Hairy Cell
8
Neoplasm, Residual
5
Lymphoproliferative Disorders
5
Hodgkin Disease
5
Hematologic Neoplasms
5
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
4
Myelodysplastic Syndromes
4
Leukemia, Myeloid, Acute
4
Hematologic Diseases
4
Dendritic Cell Sarcoma, Interdigitating
4
Lymphoma, AIDS-Related
3
Leukemia, Myeloid, Accelerated Phase
3
Leukemia, Biphenotypic, Acute
3
Epstein-Barr Virus Infections
3
beta-Thalassemia
2
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
2
Interventions
pembrolizumab
1
Cholecalciferol
1
10-propargyl-10-deazaaminopterin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Subcutaneous panniculitis-like T-cell lymphoma
×
Rituximab
×
1 year
×
Clear all
No trials found.